ReviewFrontiers in oncology2026

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions.

Maen Abdelrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.